Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ENPH vs GSK✓SelectedUSD · GSKENPH vs GSK performance historyLatest closeAs of-1.73%11/18
Stock and ETF performance explorer

ENPH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,998.1%
GSK return
+100.8%
Excess return
+1,897.3%
Maximum drawdown
-93.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-1.3%-0.4%-1.1%
7D-19.9%-3.1%-16.8%-18.7%
30D-26.0%-0.9%-25.1%-25.5%
3M-39.7%-4.2%-35.5%-38.6%
6M-54.4%-1.6%-52.8%-54.6%
YTD-29.3%+2.6%-31.9%-30.5%
1Y-17.9%+6.2%-24.1%-20.5%
3Y-75.6%+55.0%-130.6%-80.7%
5Y-91.1%+42.8%-133.9%-92.8%
All+1,998.1%+100.8%+1,897.3%+1,301.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling